Literature DB >> 26425458

Surgical approaches for liver metastases in carcinoid tumors.

Emad Kandil1, Ahmad Saeed1, Joseph Buell1.   

Abstract

Liver is the commonest site for metastasis in patients with neuroendocrine tumors (NETs); it occurs in 45-95% of patients. Available treatment options include surgical resection, liver transplantation, chemotherapy and biotherapy. Surgery is the gold standard for curative therapy. Typically, a multidisciplinary approach is a cornerstone for decision making while dealing with this aggressive disease. This review will focus on the performance and safety of open, laparoscopic, and liver transplant surgical approaches in NETs patients with liver metastases.

Entities:  

Keywords:  Neuroendocrine tumors (NETs); laparoscopic hepatic resection; liver metastases; liver transplant

Year:  2015        PMID: 26425458      PMCID: PMC4561664          DOI: 10.3978/j.issn.2227-684X.2015.04.10

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  19 in total

1.  ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

Authors:  Marianne Pavel; Eric Baudin; Anne Couvelard; Eric Krenning; Kjell Öberg; Thomas Steinmüller; Martin Anlauf; Bertram Wiedenmann; Ramon Salazar
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

2.  Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?

Authors:  Vincenzo Mazzaferro; Andrea Pulvirenti; Jorgelina Coppa
Journal:  J Hepatol       Date:  2007-07-26       Impact factor: 25.083

3.  Surgical management of liver metastases from gastrointestinal endocrine tumors.

Authors:  E Boleslawski; S Dharancy; S Truant; F-R Pruvot
Journal:  Gastroenterol Clin Biol       Date:  2010-03-26

4.  [Poorly differentiated neuroendocrine small-cell carcinoma of the gallbladder].

Authors:  M Benkel; F Brasch; J D Neumann; A Altendorf-Hofmann; W Sendt
Journal:  Zentralbl Chir       Date:  2011-03-01       Impact factor: 0.942

Review 5.  Therapeutic strategies for neuroendocrine liver metastases.

Authors:  Andrea Frilling; Ashley K Clift
Journal:  Cancer       Date:  2014-10-01       Impact factor: 6.860

Review 6.  Complications of radiofrequency coagulation of liver tumours.

Authors:  S Mulier; P Mulier; Y Ni; Y Miao; B Dupas; G Marchal; I De Wever; L Michel
Journal:  Br J Surg       Date:  2002-10       Impact factor: 6.939

7.  Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure.

Authors:  D T O'Connor; M R Pandlan; E Carlton; J H Cervenka; R J Hslao
Journal:  Clin Chem       Date:  1989-08       Impact factor: 8.327

8.  The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum.

Authors:  Lowell B Anthony; Jonathan R Strosberg; David S Klimstra; William J Maples; Thomas M O'Dorisio; Richard R P Warner; Gregory A Wiseman; Al B Benson; Rodney F Pommier
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

9.  Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report.

Authors:  Y P Le Treut; E Grégoire; J Belghiti; O Boillot; O Soubrane; G Mantion; D Cherqui; D Castaing; P Ruszniewski; P Wolf; F Paye; E Salame; F Muscari; F R Pruvot; J Baulieux
Journal:  Am J Transplant       Date:  2008-04-29       Impact factor: 8.086

10.  The international position on laparoscopic liver surgery: The Louisville Statement, 2008.

Authors:  Joseph F Buell; Daniel Cherqui; David A Geller; Nicholas O'Rourke; David Iannitti; Ibrahim Dagher; Alan J Koffron; Mark Thomas; Brice Gayet; Ho Seong Han; Go Wakabayashi; Giulio Belli; Hironori Kaneko; Chen-Guo Ker; Olivier Scatton; Alexis Laurent; Eddie K Abdalla; Prosanto Chaudhury; Erik Dutson; Clark Gamblin; Michael D'Angelica; David Nagorney; Giuliano Testa; Daniel Labow; Derrik Manas; Ronnie T Poon; Heidi Nelson; Robert Martin; Bryan Clary; Wright C Pinson; John Martinie; Jean-Nicolas Vauthey; Robert Goldstein; Sasan Roayaie; David Barlet; Joseph Espat; Michael Abecassis; Myrddin Rees; Yuman Fong; Kelly M McMasters; Christoph Broelsch; Ron Busuttil; Jacques Belghiti; Steven Strasberg; Ravi S Chari
Journal:  Ann Surg       Date:  2009-11       Impact factor: 12.969

View more
  2 in total

Review 1.  Is there any role for minimally invasive surgery in NET?

Authors:  M Thomaschewski; H Neeff; T Keck; H P H Neumann; T Strate; E von Dobschuetz
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 2.  Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors.

Authors:  Ugo Marchese; Martin Gaillard; Anna Pellat; Stylianos Tzedakis; Einas Abou Ali; Anthony Dohan; Maxime Barat; Philippe Soyer; David Fuks; Romain Coriat
Journal:  Cancers (Basel)       Date:  2022-01-15       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.